ConfometRx

ConfometRx is developing a structure-based drug discovery platform to facilitate target validation, lead identification, and optimization for G protein-coupled receptor (GPCR) targets. ConfometRx is currently advancing several small molecule candidates through lead optimization and preclinical development targeting GPCR targets for central nervous system, respiratory, metabolic, and other diseases.